Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

In re Khan, No. 25-139 (Fed. Cir. Sept. 29, 2025)

Denied
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 25-139
Decided
September 29, 2025
Judge
Per curiam
Document
Nonprecedential Opinion
Length
3 pages

NOTE: This order is nonprecedential. United States Court of Appeals

for the Federal Circuit

In Re NAZIR KHAN, IFTIKHAR KHAN,

Petitioners

2025-139

On Petition for Writ of Mandamus to the United States District Court for the District of Utah in No. 2:21-cv-00337-HCN-CMR, Judge Howard C. Nielson, Jr.

In Re NAZIR KHAN, IFTIKHAR KHAN,

Petitioners

2025-140

On Petition for Writ of Mandamus to the United States District Court for the Northern District of Georgia in No. 1:21-cv-02291-SCJ, Judge Steve C. Jones.

ON PETITION

Before LOURIE, PROST, and CHEN, Circuit Judges.

2O R D E R

This court previously affirmed final judgments against Nazir Khan and Iftikhar Khan on their claims of patent infringement.1 The Khans now petition this court for a writ of mandamus seeking various relief, including to declare “all dispositive rulings issued” in the cases “void” and to “[a]knowledge and confirm that all facts and legal arguments presented by Petitioners are correct in law and supported by the uncontested record.” Pets. at 9–10 (emphasis omitted).

Mandamus is an extraordinary remedy available only where the petitioner shows: (1) a clear and indisputable right to relief; (2) no adequate alternative avenue for relief; and (3) that mandamus is appropriate under the circumstances. Cheney v. U.S. Dist. Ct. for D.C., 542 U.S. 367, 380–81 (2004). To the extent the Khans are attempting to relitigate the earlier judgments, they lost the first time around on appeal and mandamus does not afford them a second bite at the apple. To the extent they are attempting to challenge rulings since that time, they have not shown a timely direct appeal would be inadequate. We have also considered their arguments to compel the trial court to take further action but find nothing in them that would warrant granting this extraordinary relief.

Accordingly,

3IT IS ORDERED THAT:

The petitions are denied.

FOR THE COURT

Figure on page 3 of the opinion

September 29, 2025

Date

Footnotes

  1. 1 Khan v. Merit Medical Sys., Inc., No. 2023-2329, ECF No. 69 (Fed. Cir. July 16, 2024); Khan v. Artivion, Inc., No. 2023-2347, ECF No. 43 (Fed. Cir. July 16, 2024).

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

In re Khan, No. 25-139 (Fed. Cir. Sept. 29, 2025).

Record ID
CAFC-25-139-20250929
Permalink
https://patentcasewatch.com/opinions/CAFC-25-139-20250929

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.